{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T09:02:19Z","timestamp":1793437339116,"version":"4.5.0"},"reference-count":42,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1821,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1111\/j.1465-3362.2010.00237.x","type":"journal-article","created":{"date-parts":[[2010,9,6]],"date-time":"2010-09-06T07:57:50Z","timestamp":1283759870000},"page":"388-396","source":"Crossref","is-referenced-by-count":56,"title":["Methadone maintenance, QTc and torsade de pointes: Who needs an electrocardiogram and what is the prevalence of QTc prolongation?"],"prefix":"10.1111","volume":"30","author":[{"given":"SORAYA","family":"MAYET","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MICHAEL","family":"GOSSOP","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NICHOLAS","family":"LINTZERIS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VIAS","family":"MARKIDES","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JOHN","family":"STRANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,9,6]]},"reference":[{"issue":"2","key":"10.1111\/j.1465-3362.2010.00237.x-BIB1|cit1","first-page":"CD002209","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.7326\/0003-4819-137-6-200209170-00010","article-title":"Torsade de pointes associated with very-high-dose methadone","volume":"137","author":"Krantz","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1592\/phco.23.6.802.32186","article-title":"Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes","volume":"23","author":"Krantz","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0002-8703(73)90344-X","article-title":"The effect of heroin and multiple drug abuse on the electrocardiogram","volume":"86","author":"Lipski","year":"1973","journal-title":"Am Heart J"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB5|cit5","unstructured":"EMEA EMEA Public Statement on the recommendation to suspend the marketing authorisation for ORLAAM (Levacetylmethadol) in the European Union European Medicines Agency 2001 http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Public_statement\/2009\/12\/WC500018335.pdf"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB6|cit6","first-page":"272","article-title":"Comparison of the effects of methadone and LAAM on the Electrocardiogram","volume":"63","author":"Huber","year":"2001","journal-title":"Drug Alcohol Depend"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB7|cit7","unstructured":"MHRA and Commission on Human Medicines Risk of QT interval prolongation with methadone 2006 May"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB8|cit8","unstructured":"US Food and Drug Administration Methadone use for pain control may result in death and life-threatening changes in breathing and heart beat"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"23B","DOI":"10.1016\/0002-9149(93)90036-C","article-title":"Measurement of the QT interval and the risk associated with QTc interval prolongation: a review","volume":"72","author":"Moss","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB10|cit10","unstructured":"EMEA ICH Topic E 14: the clinical evaluation of QT\/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs European Medicines Agency 2005 http:\/\/www.ich.org\/LOB\/media\/MEDIA1476.pdf"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"50B","DOI":"10.1016\/0002-9149(93)90041-A","article-title":"Is QT interval prolongation harmful? A regulatory perspective","volume":"72","author":"Botstein","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1172\/JCI26381","article-title":"Mechanisms of sudden cardiac death","volume":"115","author":"Rubart","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0002-9149(03)00906-8","article-title":"QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone. [See comment]","volume":"92","author":"Gil","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/pds.1112","article-title":"QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system","volume":"14","author":"Pearson","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/01.jcp.0000132347.81455.57","article-title":"QT interval prolongation in patients on methadone with concomitant drugs","volume":"24","author":"Piguet","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB16|cit16","first-page":"282","article-title":"Methadone-induced Torsade de pointes tachycardias","volume":"135","author":"Sticherling","year":"2005","journal-title":"Swiss Med Wkly"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jpainsymman.2004.06.012","article-title":"Measurement of QTc in patients receiving chronic methadone therapy","volume":"29","author":"Cruciani","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/hrt.2006.100180","article-title":"Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen","volume":"93","author":"Fanoe","year":"2007","journal-title":"Heart"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.drugalcdep.2008.06.018","article-title":"Prevalence of long QTc interval in methadone maintenance patients","volume":"99","author":"Fonseca","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1360-0443.2006.01668.x","article-title":"Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study","volume":"102","author":"Peles","year":"2007","journal-title":"Addiction"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jpainsymman.2006.02.010","article-title":"Opioid switching from morphine to methadone causes a minor but not clinically significant increase in QTc time: a prospective 9-month follow-up study","volume":"32","author":"Fredheim","year":"2006","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.amjcard.2004.11.055","article-title":"Impact of methadone treatment on cardiac repolarization and conduction in opioid users","volume":"95","author":"Martell","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1001\/archinte.167.22.2469","article-title":"QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial","volume":"167","author":"Wedam","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1124\/jpet.102.038240","article-title":"Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents","volume":"303","author":"Katchman","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB25|cit25","first-page":"2940","article-title":"Routine ECG in methadone-assisted rehabilitation is wrong prioritization. [Norwegian]","volume":"124","author":"Krook","year":"2004","journal-title":"Tidsskr Nor Laegeforen"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB26|cit26","unstructured":"MEDSAFE Cardiac Vigilance Recommended for Methadone: New Zealand Medicines and Medical Devices Safety Authority"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB27|cit27","volume-title":"Drug misuse and dependence: UK guidelines on clinical management","author":"DH","year":"2007"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1046\/j.1360-0443.1998.9312185711.x","article-title":"The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome 332","volume":"93","author":"Marsden","year":"1998","journal-title":"Addiction"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1177\/0091270006286900","article-title":"Man versus machine: is there an optimal method for QT measurements in thorough QT studies?","volume":"46","author":"Darpo","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB30|cit30","unstructured":"Mayet S QT Prolongation and Opioid Maintenance Treatment Doctor of Medcine Thesis 2009"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/10550880903436044","article-title":"Onsite QTc interval screening for patients in methadone maintenance treatment","volume":"29","author":"Fareed","year":"2010","journal-title":"J Addict Dis"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0304-3959(03)00205-7","article-title":"QTc interval prolongation associated with intravenous methadone","volume":"105","author":"Kornick","year":"2003","journal-title":"Pain"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB33|cit33","unstructured":"ABPI Medicines compendium 2008: summary of product characteristics 2008"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1360-0443.2009.02549.x","article-title":"Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study","volume":"104","author":"Anchersen","year":"2009","journal-title":"Addiction"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/10550880802122596","article-title":"Electrocardiogram characteristics of methadone and buprenorphine maintained subjects","volume":"27","author":"Athanasos","year":"2008","journal-title":"J Addict Dis"},{"issue":"3","key":"10.1111\/j.1465-3362.2010.00237.x-BIB36|cit36","first-page":"CD002208","article-title":"Methadone maintenance at different dosages for opioid dependence","author":"Faggiano","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/archinte.166.12.1280","article-title":"Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors. [See comment]","volume":"166","author":"Ehret","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1540-8167.2006.00421.x","article-title":"Intravenous cocaine and QT variability","volume":"17","author":"Haigney","year":"2006","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1300\/J069v24n01_05","article-title":"Cocaine-related torsade de pointes in a methadone maintenance patient","volume":"24","author":"Krantz","year":"2005","journal-title":"J Addict Dis"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"387","DOI":"10.7326\/0003-4819-150-6-200903170-00103","article-title":"QTc interval screening in methadone treatment","volume":"150","author":"Krantz","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-151-3-200908040-00014","article-title":"Concerns about consensus guidelines for QTc interval screening in methadone treatment417","volume":"151","author":"Cohen","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1465-3362.2010.00237.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1360-0443.2007.01762.x","article-title":"Does prescribing for opiate addiction change after national guidelines? Methadone and buprenorphine prescribing to opiate addicts by general practitioners and hospital doctors in England, 1995-2005","volume":"102","author":"Strang","year":"2007","journal-title":"Addiction"}],"container-title":["Drug and Alcohol Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1465-3362.2010.00237.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1465-3362.2010.00237.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T08:39:39Z","timestamp":1625647179000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1465-3362.2010.00237.x"}},"subtitle":["Methadone maintenance and QTc"],"short-title":[],"issued":{"date-parts":[[2010,9,6]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1465-3362.2010.00237.x","relation":{},"ISSN":["0959-5236"],"issn-type":[{"value":"0959-5236","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9,6]]}}}